Reedley College Secures $2.

Peel Therapeutics

Over the course of millions of years, nature evolved to create the world’s most awe-inspiring, life-changing health outcomes. Peel Therapeutics translates these evolutionary outliers to develop medicines for patients with cancer and inflammatory diseases. Using scientific and medical expertise, state-of-the-art technology and drug development knowledge, we redesign what nature offers into medicines for patients by tackling solubility, scalability, and bioavailability. Our clinical stage therapeutic pipeline treats a spectrum of devastating conditions, with a near-term focus on cancer and inflammation. At Peel Therapeutics, we push the limits of biology to develop highly effective and safe medicines for patients that transcend the incremental.

HavocAI

Havoc is the leader in all-domain collaborative autonomy. Its software-defined hardware approach powers military and commercial-grade autonomous systems across sea, air, and land to sense, decide, and act together in complex and contested environments. Havoc connects assets, enabling them to share information, adapt in real time, and continue operating even when communications are disrupted or denied. Havoc was founded in 2024 and headquartered in Providence, Rhode Island. Learn more at havocai.com.

KinetiTec, Inc.

KinetiTec™ is poised to define a new category of care: in-bed mobility intelligence. We’re tackling hospital-acquired complications and immobility harm to reduce costs to healthcare systems and extend the reach of physical therapy. Our mission: break the cycle of immobility and hospital-acquired deconditioning, a critical and often overlooked healthcare challenge that costs the U.S. over $800M annually. Alarmingly, nearly one-third of patients leave the hospital more debilitated than when they arrived — primarily due to prolonged immobility. Our innovative solution is designed to tackle this issue head-on, addressing key pain points for patients, healthcare providers, and institutions alike. KinetiTec Spark™ addresses a critical gap in inpatient mobility by objectively quantifying strength maintenance and activity progression. By transforming recumbent movement into measurable data, SPARK supports more informed clinical decisions around mobility readiness, discharge planning, and post-surgical recovery pathways. We aim to impact the time it takes for vulnerable individuals to return home and regain their independence. We are committed to patients and caregivers and to supporting a healthcare environment where mobility is prioritized, recovery is accelerated, and lives are changed for the better.

Concentrate AI

It should be easy to use any LLM you want. That's why we're building Concentrate. One API for all models across all providers. We handle reliability, governance, observability, and infrastructure to save you money and make this possible. Backed by RRE Ventures, True Ventures, and other top-tier VCs.

esVolta, LP

Focused on sustainability and innovation, esVolta develops, owns, and operates reliable utility-scale energy storage assets across the entire lifecycle - delivering value for utilities, energy users, and investors.